FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118193590> ?p ?o ?g. }

• W2118193590 endingPage "1233" @default.
• W2118193590 startingPage "1233" @default.
• W2118193590 abstract "To compare the remission rate and its time-course over 196 wk of double-blind treatment with an atypical antipsychotic, ziprasidone (80–160 mg/d given b.i.d., or 80–120 mg/d given q.d.), or a conventional antipsychotic, haloperidol (5–20 mg/d). Outcome assessments included attainment of remission (Andreasen criteria) by longitudinal analysis. Positive and Negative Syndrome Scale (PANSS) scores, Global Assessment of Functioning Scale (GAF) scores, and quality-of-life (QLS) were also assessed in the initial 40-wk study phase (n=599) and the 3-yr extension study (n=186). Discontinuation rates in the initial 40-wk core and follow-up extension studies were comparable between groups: 64% and 65% for the 80–160 mg/d ziprasidone group, 65% and 58% for the 80–120 mg/d ziprasidone group, and 60% and 66% for the 5–20 mg/d haloperidol group, respectively. Mean change scores from baseline to LOCF endpoint (week 40 or early termination) for PANSS negative and GAF (primary efficacy variables) were not statistically significantly different between ziprasidone and haloperidol. During the 3-yr extension study, ziprasidone-treated subjects (80–160 mg/d) were more likely to achieve remission (51%) than haloperidol-treated (40%) subjects (p=0.04), while there was a favourable trend associated with 80–120 mg/d ziprasidone (48%). Compared to the haloperidol group, subjects assigned to the 80–160 mg/d ziprasidone group showed a gradual and persistent improvement in remission (p=0.006) and quality-of-life (p=0.004) in the longitudinal analyses. Significant differences in the trajectory of PANSS total and GAF scores favouring the 80–160 mg/d ziprasidone group were also observed. In this long-term, double-blind study, ziprasidone treatment was more likely to result in remission than haloperidol treatment, and was associated with greater improvement in quality-of-life." @default.
• W2118193590 created "2016-06-24" @default.
• W2118193590 creator A5005473186 @default.
• W2118193590 creator A5009946921 @default.
• W2118193590 creator A5066553937 @default.
• W2118193590 creator A5072573097 @default.
• W2118193590 creator A5083859235 @default.
• W2118193590 creator A5084671689 @default.
• W2118193590 date "2009-05-07" @default.
• W2118193590 modified "2023-09-25" @default.
• W2118193590 title "Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol" @default.
• W2118193590 cites W1514982086 @default.
• W2118193590 cites W1704420030 @default.
• W2118193590 cites W1975916217 @default.
• W2118193590 cites W1976706794 @default.
• W2118193590 cites W1992717820 @default.
• W2118193590 cites W1999689270 @default.
• W2118193590 cites W2005567237 @default.
• W2118193590 cites W2007865301 @default.
• W2118193590 cites W2014659531 @default.
• W2118193590 cites W2022528264 @default.
• W2118193590 cites W2034758005 @default.
• W2118193590 cites W2053301065 @default.
• W2118193590 cites W2054929834 @default.
• W2118193590 cites W2061276728 @default.
• W2118193590 cites W2063674695 @default.
• W2118193590 cites W2090828958 @default.
• W2118193590 cites W2096279273 @default.
• W2118193590 cites W2100984327 @default.
• W2118193590 cites W2101639971 @default.
• W2118193590 cites W2109196233 @default.
• W2118193590 cites W2118940666 @default.
• W2118193590 cites W2127313266 @default.
• W2118193590 cites W2132873362 @default.
• W2118193590 cites W2135689380 @default.
• W2118193590 cites W2140606211 @default.
• W2118193590 cites W2149639459 @default.
• W2118193590 cites W2159039084 @default.
• W2118193590 cites W2159155203 @default.
• W2118193590 cites W2165379748 @default.
• W2118193590 cites W2318857297 @default.
• W2118193590 cites W4234076493 @default.
• W2118193590 cites W4239268844 @default.
• W2118193590 cites W4243688722 @default.
• W2118193590 cites W4252920625 @default.
• W2118193590 cites W70314342 @default.
• W2118193590 doi "https://doi.org/10.1017/s1461145709000352" @default.
• W2118193590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19419595" @default.
• W2118193590 hasPublicationYear "2009" @default.
• W2118193590 type Work @default.
• W2118193590 sameAs 2118193590 @default.
• W2118193590 citedByCount "35" @default.
• W2118193590 countsByYear W21181935902012 @default.
• W2118193590 countsByYear W21181935902013 @default.
• W2118193590 countsByYear W21181935902014 @default.
• W2118193590 countsByYear W21181935902015 @default.
• W2118193590 countsByYear W21181935902016 @default.
• W2118193590 countsByYear W21181935902018 @default.
• W2118193590 countsByYear W21181935902022 @default.
• W2118193590 crossrefType "journal-article" @default.
• W2118193590 hasAuthorship W2118193590A5005473186 @default.
• W2118193590 hasAuthorship W2118193590A5009946921 @default.
• W2118193590 hasAuthorship W2118193590A5066553937 @default.
• W2118193590 hasAuthorship W2118193590A5072573097 @default.
• W2118193590 hasAuthorship W2118193590A5083859235 @default.
• W2118193590 hasAuthorship W2118193590A5084671689 @default.
• W2118193590 hasBestOaLocation W21181935901 @default.
• W2118193590 hasConcept C118552586 @default.
• W2118193590 hasConcept C126322002 @default.
• W2118193590 hasConcept C15744967 @default.
• W2118193590 hasConcept C2776412080 @default.
• W2118193590 hasConcept C2776921671 @default.
• W2118193590 hasConcept C2777270317 @default.
• W2118193590 hasConcept C2778715236 @default.
• W2118193590 hasConcept C2779727114 @default.
• W2118193590 hasConcept C2780135775 @default.
• W2118193590 hasConcept C2780200951 @default.
• W2118193590 hasConcept C2780494398 @default.
• W2118193590 hasConcept C2780948584 @default.
• W2118193590 hasConcept C513476851 @default.
• W2118193590 hasConcept C71924100 @default.
• W2118193590 hasConceptScore W2118193590C118552586 @default.
• W2118193590 hasConceptScore W2118193590C126322002 @default.
• W2118193590 hasConceptScore W2118193590C15744967 @default.
• W2118193590 hasConceptScore W2118193590C2776412080 @default.
• W2118193590 hasConceptScore W2118193590C2776921671 @default.
• W2118193590 hasConceptScore W2118193590C2777270317 @default.
• W2118193590 hasConceptScore W2118193590C2778715236 @default.
• W2118193590 hasConceptScore W2118193590C2779727114 @default.
• W2118193590 hasConceptScore W2118193590C2780135775 @default.
• W2118193590 hasConceptScore W2118193590C2780200951 @default.
• W2118193590 hasConceptScore W2118193590C2780494398 @default.
• W2118193590 hasConceptScore W2118193590C2780948584 @default.
• W2118193590 hasConceptScore W2118193590C513476851 @default.
• W2118193590 hasConceptScore W2118193590C71924100 @default.
• W2118193590 hasIssue "09" @default.
• W2118193590 hasLocation W21181935901 @default.
• W2118193590 hasLocation W21181935902 @default.

• next